PEARSON TIMOTHY R
Insider CIK 1528617 · CHSI EVP & Chief Financial Officer · GLYC Director · RARX Director · TSRO Executive VP and CFO · KRRO Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KRRO Korro Bio, Inc. | A Award deriv | 2026-06-10 | 2026-06-11 | 14,677 | — | $0 | 14,677 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2025-06-11 | 2025-06-12 | 6,010 | — | $0 | 6,010 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2024-06-11 | 2024-06-12 | 5,190 | — | $0 | 5,190 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2024-05-01 | 2024-05-01 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KRRO Korro Bio, Inc. | A Award deriv | 2023-11-03 | 2023-11-07 | 16,000 | — | $0 | 16,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2023-05-19 | 2023-05-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | P Buy | 2022-11-11 | 2022-11-14 | 19,400 | $1.29 | $25.0K | 24,650 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2022-05-18 | 2022-05-20 | 21,000 | — | $0 | 21,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2021-05-18 | 2021-05-27 | 10,500 | — | $0 | 10,500 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award | 2021-05-18 | 2021-05-27 | 5,250 | — | $0 | 5,250 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2020-05-22 | 2020-05-27 | 21,000 | — | $0 | 21,000 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 22,857 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | D To issuer deriv | 2020-04-02 | 2020-04-03 | 15,000 | — | $0 | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2019-06-11 | 2019-06-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2019-05-17 | 2019-05-21 | 21,000 | — | $0 | 21,000 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 35,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 31,954 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 10,782 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 8,750 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 4,447 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 18,182 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 125,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | D To issuer deriv | 2019-01-22 | 2019-01-22 | 55,000 | — | $0 | 0 | SEC↗ |
| TSRO TESARO, Inc. | U Tender | 2019-01-22 | 2019-01-22 | 6,211 | $75.00 | $465.8K | 0 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2018-06-28 | 2018-07-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2018-05-18 | 2018-05-21 | 11,000 | — | $0 | 11,000 | SEC↗ |
| TSRO TESARO, Inc. | S Sale | 2018-03-02 | 2018-03-05 | 2,575 | $54.86 | $141.3K | 6,211 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-03-01 | 2018-03-05 | 31,954 | — | $0 | 31,954 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2018-03-01 | 2018-03-05 | 18,182 | — | $0 | 18,182 | SEC↗ |
| TSRO TESARO, Inc. | M Exercise deriv | 2018-03-01 | 2018-03-05 | 1,483 | — | $0 | 4,447 | SEC↗ |
| TSRO TESARO, Inc. | M Exercise deriv | 2018-03-01 | 2018-03-05 | 4,375 | — | $0 | 8,750 | SEC↗ |
| TSRO TESARO, Inc. | M Exercise | 2018-03-01 | 2018-03-05 | 1,483 | — | $0 | 8,786 | SEC↗ |
| TSRO TESARO, Inc. | M Exercise | 2018-03-01 | 2018-03-05 | 4,375 | — | $0 | 7,303 | SEC↗ |
| RARX Ra Pharmaceuticals, Inc. | A Award deriv | 2017-06-20 | 2017-06-22 | 15,000 | — | $0 | 15,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2017-05-25 | 2017-05-30 | 11,000 | — | $0 | 11,000 | SEC↗ |
| TSRO TESARO, Inc. | S Sale | 2017-03-02 | 2017-03-03 | 1,447 | $177.61 | $257.0K | 2,928 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2017-03-01 | 2017-03-03 | 5,930 | — | $0 | 5,930 | SEC↗ |
| TSRO TESARO, Inc. | M Exercise deriv | 2017-03-01 | 2017-03-03 | 4,375 | — | $0 | 13,125 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2017-03-01 | 2017-03-03 | 10,782 | — | $0 | 10,782 | SEC↗ |
| TSRO TESARO, Inc. | M Exercise | 2017-03-01 | 2017-03-03 | 4,375 | — | $0 | 4,375 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2016-05-17 | 2016-05-19 | 11,000 | — | $0 | 11,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2016-05-17 | 2016-05-19 | 11,000 | — | $0 | 11,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2016-03-01 | 2016-03-03 | 35,000 | — | $0 | 35,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2016-03-01 | 2016-03-03 | 17,500 | — | $0 | 17,500 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2015-07-15 | 2015-08-11 | 11,000 | — | $0 | 11,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2015-03-06 | 2015-03-10 | 55,000 | — | $0 | 55,000 | SEC↗ |
| TSRO TESARO, Inc. | A Award deriv | 2014-05-27 | 2014-05-29 | 125,000 | — | $0 | 125,000 | SEC↗ |
| GLYC GLYCOMIMETICS INC | A Award deriv | 2014-03-31 | 2014-04-01 | 15,401 | — | $0 | 15,401 | SEC↗ |
| CHSI CATALYST HEALTH SOLUTIONS, | D To issuer | 2012-07-02 | 2012-07-05 | 40,000 | — | $0 | 0 | SEC↗ |
| CHSI CATALYST HEALTH SOLUTIONS, | A Award | 2012-02-23 | 2012-02-27 | 10,000 | — | $0 | 40,000 | SEC↗ |